Cardiology

Relative risk for CVT up after AZD1222 COVID-19 vaccine

The relative rates of hospital contacts for coagulation disorder and cerebrovascular disease are increased after AZD1222 COVID-19 vaccination, particularly for thrombocytopenia and cerebral venous thrombosis, according to ...

Medical research

Using Epo to treat COVID-19

Erythropoietin (Epo) is actually a medication for anemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth ...

Medications

Semaglutide superior to liraglutide for weight loss

(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous ...

page 2 from 40